vs
Side-by-side financial comparison of IRONWOOD PHARMACEUTICALS INC (IRWD) and Silvercrest Asset Management Group Inc. (SAMG). Click either name above to swap in a different company.
IRONWOOD PHARMACEUTICALS INC is the larger business by last-quarter revenue ($47.7M vs $32.0M, roughly 1.5× Silvercrest Asset Management Group Inc.). Silvercrest Asset Management Group Inc. runs the higher net margin — -0.4% vs -4.8%, a 4.4% gap on every dollar of revenue. On growth, Silvercrest Asset Management Group Inc. posted the faster year-over-year revenue change (-0.0% vs -47.3%). IRONWOOD PHARMACEUTICALS INC produced more free cash flow last quarter ($74.6M vs $15.0M). Over the past eight quarters, Silvercrest Asset Management Group Inc.'s revenue compounded faster (2.7% CAGR vs -20.2%).
Ironwood Pharmaceuticals, Inc. is a publicly traded pharmaceutical company. It was originally called Microbia, Inc.
IRWD vs SAMG — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $47.7M | $32.0M |
| Net Profit | $-2.3M | $-120.0K |
| Gross Margin | — | — |
| Operating Margin | 14.3% | -2.8% |
| Net Margin | -4.8% | -0.4% |
| Revenue YoY | -47.3% | -0.0% |
| Net Profit YoY | -200.9% | -107.4% |
| EPS (diluted) | $0.01 | $0.02 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $47.7M | $32.0M | ||
| Q3 25 | $122.1M | $31.3M | ||
| Q2 25 | $85.2M | $30.7M | ||
| Q1 25 | $41.1M | $31.4M | ||
| Q4 24 | $90.5M | $32.0M | ||
| Q3 24 | $91.6M | $30.4M | ||
| Q2 24 | $94.4M | $31.0M | ||
| Q1 24 | $74.9M | $30.3M |
| Q4 25 | $-2.3M | $-120.0K | ||
| Q3 25 | $40.1M | $618.0K | ||
| Q2 25 | $23.6M | $1.9M | ||
| Q1 25 | $-37.4M | $2.5M | ||
| Q4 24 | $2.3M | $1.6M | ||
| Q3 24 | $3.6M | $2.3M | ||
| Q2 24 | $-860.0K | $2.7M | ||
| Q1 24 | $-4.2M | $3.0M |
| Q4 25 | 14.3% | -2.8% | ||
| Q3 25 | 61.8% | 4.3% | ||
| Q2 25 | 53.2% | 13.2% | ||
| Q1 25 | -70.7% | 15.4% | ||
| Q4 24 | 34.8% | 6.1% | ||
| Q3 24 | 28.0% | 14.6% | ||
| Q2 24 | 26.5% | 17.1% | ||
| Q1 24 | 14.7% | 19.5% |
| Q4 25 | -4.8% | -0.4% | ||
| Q3 25 | 32.8% | 2.0% | ||
| Q2 25 | 27.7% | 6.3% | ||
| Q1 25 | -90.9% | 7.9% | ||
| Q4 24 | 2.5% | 5.1% | ||
| Q3 24 | 4.0% | 7.4% | ||
| Q2 24 | -0.9% | 8.6% | ||
| Q1 24 | -5.6% | 9.9% |
| Q4 25 | $0.01 | $0.02 | ||
| Q3 25 | $0.23 | $0.07 | ||
| Q2 25 | $0.14 | $0.21 | ||
| Q1 25 | $-0.23 | $0.26 | ||
| Q4 24 | $0.03 | $0.16 | ||
| Q3 24 | $0.02 | $0.24 | ||
| Q2 24 | $-0.01 | $0.28 | ||
| Q1 24 | $-0.03 | $0.32 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $215.5M | $44.1M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $-261.8M | $50.3M |
| Total Assets | $396.9M | $166.6M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $215.5M | $44.1M | ||
| Q3 25 | $140.4M | $36.1M | ||
| Q2 25 | $92.9M | $30.0M | ||
| Q1 25 | $108.5M | $36.3M | ||
| Q4 24 | $88.6M | $68.6M | ||
| Q3 24 | $88.2M | $58.1M | ||
| Q2 24 | $105.5M | $49.9M | ||
| Q1 24 | $121.5M | $39.7M |
| Q4 25 | — | — | ||
| Q3 25 | $199.5M | — | ||
| Q2 25 | $199.3M | — | ||
| Q1 25 | $199.2M | — | ||
| Q4 24 | $199.0M | — | ||
| Q3 24 | $198.8M | — | ||
| Q2 24 | $198.6M | — | ||
| Q1 24 | $398.3M | — |
| Q4 25 | $-261.8M | $50.3M | ||
| Q3 25 | $-264.2M | $58.9M | ||
| Q2 25 | $-308.2M | $64.6M | ||
| Q1 25 | $-334.1M | $80.0M | ||
| Q4 24 | $-301.3M | $80.7M | ||
| Q3 24 | $-311.3M | $84.6M | ||
| Q2 24 | $-321.7M | $85.3M | ||
| Q1 24 | $-330.5M | $83.9M |
| Q4 25 | $396.9M | $166.6M | ||
| Q3 25 | $396.1M | $157.6M | ||
| Q2 25 | $342.9M | $152.7M | ||
| Q1 25 | $327.2M | $159.9M | ||
| Q4 24 | $350.9M | $194.4M | ||
| Q3 24 | $389.5M | $184.2M | ||
| Q2 24 | $395.6M | $177.6M | ||
| Q1 24 | $438.8M | $170.2M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $74.6M | $18.6M |
| Free Cash FlowOCF − Capex | $74.6M | $15.0M |
| FCF MarginFCF / Revenue | 156.3% | 46.9% |
| Capex IntensityCapex / Revenue | 0.0% | 11.4% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $127.0M | $17.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $74.6M | $18.6M | ||
| Q3 25 | $47.6M | $14.6M | ||
| Q2 25 | $-15.1M | $13.8M | ||
| Q1 25 | $20.0M | $-24.7M | ||
| Q4 24 | $15.2M | $21.6M | ||
| Q3 24 | $9.9M | $13.3M | ||
| Q2 24 | $33.5M | $16.0M | ||
| Q1 24 | $45.0M | $-24.1M |
| Q4 25 | $74.6M | $15.0M | ||
| Q3 25 | $47.6M | $13.8M | ||
| Q2 25 | $-15.1M | $13.4M | ||
| Q1 25 | $19.9M | $-25.1M | ||
| Q4 24 | — | $19.9M | ||
| Q3 24 | $9.9M | $12.9M | ||
| Q2 24 | $33.4M | $15.6M | ||
| Q1 24 | $44.9M | $-24.7M |
| Q4 25 | 156.3% | 46.9% | ||
| Q3 25 | 39.0% | 44.1% | ||
| Q2 25 | -17.7% | 43.6% | ||
| Q1 25 | 48.4% | -80.0% | ||
| Q4 24 | — | 62.2% | ||
| Q3 24 | 10.8% | 42.4% | ||
| Q2 24 | 35.4% | 50.4% | ||
| Q1 24 | 60.0% | -81.6% |
| Q4 25 | 0.0% | 11.4% | ||
| Q3 25 | 0.0% | 2.6% | ||
| Q2 25 | 0.0% | 1.5% | ||
| Q1 25 | 0.1% | 1.3% | ||
| Q4 24 | 0.0% | 5.3% | ||
| Q3 24 | 0.0% | 1.2% | ||
| Q2 24 | 0.1% | 1.1% | ||
| Q1 24 | 0.1% | 2.0% |
| Q4 25 | — | — | ||
| Q3 25 | 1.19× | 23.62× | ||
| Q2 25 | -0.64× | 7.22× | ||
| Q1 25 | — | -10.01× | ||
| Q4 24 | 6.74× | 13.34× | ||
| Q3 24 | 2.71× | 5.90× | ||
| Q2 24 | — | 6.00× | ||
| Q1 24 | — | -8.03× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
IRWD
Segment breakdown not available.
SAMG
| Investment Advisory Management And Administrative Service | $30.7M | 96% |
| Tax And Family Office Services | $1.2M | 4% |
